Paper. Li H, Tang L, Zhang J et al.. Nature Communications, 17 Sep 2026.
A PNAS team took LSD's four-ring core apart into nine simpler molecules, mapped which parts drive the hallucinogenic effect, and found two candidates with lower hallucinogenic and heart risk. A Nature Communications group used cryo-EM structures to design compounds that activate 5-HT2A while blocking 5-HT2B, the receptor linked to heart valve damage.
How much weight it carries: Lab and mouse work. These molecules are years away from human testing. (Lab + mice, Drug design, Peer reviewed)
Cryo-EM structures guided compounds that activate 5-HT2A while blocking 5-HT2B.
Comparing the orthosteric pockets of the two receptors yielded a pharmacophore model and two compound series, confirmed by five further receptor-ligand structures. Selected compounds showed antidepressant-like effects in rodents.
Two cryo-EM studies built 5-HT2A agonists that actively antagonise 5-HT2B.
Comparing the binding pockets of the two receptors gave design rules — steric and conformational constraints in the side-extended and extended pockets — that were then used to make tryptamine and phenethylamine derivatives with the split profile. Selected compounds, including IHCH-2330, showed antidepressant-like effects in rodents.